Literature DB >> 629308

Intrauterine growth retardation: a preliminary report of long-term morbidity.

J A Low, R S Galbraith, D Muir, H Killen, J Karchmar, D Campbell.   

Abstract

This is a preliminary report of a prospective follow-up study of 88 intrauterine growth-retarded (IUGR) babies and a control group of 97 babies with weights appropriate for gestational age. The characteristic clinical features of IUGR pregnancies were observed in the obstetric patients of the IUGR group. The babies of the IUGR group have a phase of accelerated growth during the 3 months following delivery although they continue to be smaller than the babies of the control group at 12 months of age. No major neurologic abnormalities have been noted in the IUGR babies although behavioral differences were observed during the neonatal period and at 12 months of age. There were lower mental and physical development indices at 12 months of age which were due to the IUGR babies of lowest birth weight and those with a low maternal urinary estrogen index.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629308     DOI: 10.1016/0002-9378(78)90072-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Developmental assessment of intrauterine growth retarded babies of varying maternal etiology.

Authors:  B D Bhatia; K N Agarwal; N P Jain
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

2.  A health priority for developing countries: the prevention of chronic fetal malnutrition.

Authors:  J Villar; L Altobelli; E Kestler; J Beliźan
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

3.  Confounding variables in studying the effects of maternal alcohol consumption before and during pregnancy.

Authors:  I Walpole; S Zubrick; J Pontré
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

4.  Outcome of pregnancy in underweight women after spontaneous and induced ovulation.

Authors:  Z M van der Spuy; P J Steer; M McCusker; S J Steele; H S Jacobs
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

5.  Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).

Authors:  K E Boers; S M C Vijgen; D Bijlenga; J A M van der Post; D J Bekedam; A Kwee; P C M van der Salm; M G van Pampus; M E A Spaanderman; K de Boer; J J Duvekot; H A Bremer; T H M Hasaart; F M C Delemarre; K W M Bloemenkamp; C A van Meir; C Willekes; E J Wijnen; M Rijken; S le Cessie; F J M E Roumen; J G Thornton; J M M van Lith; B W J Mol; S A Scherjon
Journal:  BMJ       Date:  2010-12-21

6.  Evaluation of growth hormone treatment efficacy in short Japanese children born small for gestational age: Five-year treatment outcome and impact on puberty.

Authors:  Reiko Horikawa; Toshiaki Tanaka; Hiromi Nishinaga; Yoshihisa Ogawa; Susumu Yokoya
Journal:  Clin Pediatr Endocrinol       Date:  2017-04-22

7.  Delayed Bone Age Might Accelerate the Response to Human Growth Hormone Treatment in Small for Gestational Age Children with Short Stature.

Authors:  Jung-Eun Moon; Cheol Woo Ko
Journal:  Int J Endocrinol       Date:  2019-12-18       Impact factor: 3.257

8.  Maternal plasma miRNAs as potential biomarkers for detecting risk of small-for-gestational-age births.

Authors:  Sung Hye Kim; David A MacIntyre; Reem Binkhamis; Joanna Cook; Lynne Sykes; Phillip R Bennett; Vasso Terzidou
Journal:  EBioMedicine       Date:  2020-11-28       Impact factor: 8.143

9.  Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.

Authors:  Kim E Boers; Denise Bijlenga; Ben W J Mol; Saskia LeCessie; Erwin Birnie; Marielle G van Pampus; Rob H Stigter; Kitty W M Bloemenkamp; Claudia A van Meir; Joris A M van der Post; Dick J Bekedam; Lucy S M Ribbert; Addie P Drogtrop; Paulien C M van der Salm; Anjoke J M Huisjes; Christine Willekes; Frans J M E Roumen; Hubertina C J Scheepers; Karin de Boer; Johannes J Duvekot; Jim G Thornton; Sicco A Scherjon
Journal:  BMC Pregnancy Childbirth       Date:  2007-07-10       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.